4
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Combination Chemotherapy Specifically Devised for Elderly Patients with Unfavorable Non-Hodgkin's Lymphoma

, , , , , & show all
Pages 577-582 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Christine I. Chen, Peter Skingley & Ralph M. Meyer. (2000) A Comparison of Elderly Patients with Aggressive Histology Lymphoma who Were Entered or Not Entered on to a Randomized Phase II Trial. Leukemia & Lymphoma 38:3-4, pages 327-334.
Read now
F. P. J. Peters, M. A. Ten Haaft & H. C. Schouten. (1999) Intermediate and High Grade Non Hodgkin's Lymphoma in the Elderly. Leukemia & Lymphoma 33:3-4, pages 243-252.
Read now
Agustin Avilés, Angel Calva, José C. Díaz-Maqueo, Alejandra Talavera, Judith Huerta-Guzmán & Eugenio Vásquez. (1997) Dose escalation of epirubicin in the CEOP-BLEO Regimen: A Controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma. Leukemia & Lymphoma 25:3-4, pages 319-325.
Read now

Articles from other publishers (17)

Anne H. Blaes & Vicki A. Morrison. 2011. Practical Geriatric Oncology. Practical Geriatric Oncology 274 287 .
Mayumi Mori, Kiyoshi Kitamura, Michihiko Masuda, Tomomitsu Hotta, Tamotsu Miyazaki, Akira B. Miura, Hideaki Mizoguchi, Akira Shibata, Hidehiko Saito, Tamotsu Matsuda, Toru Masaoka, Mine Harada, Yoshiyuki Niho & Fumimaro Takaku. (2005) Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin's Lymphoma. International Journal of Hematology 81:3, pages 246-254.
Crossref
M. Paccalin, L. Lacotte-Thierry & V. Delwail. (2002) Traitement du lymphome malin non hodgkinien de haut grade et de stade disséminé du sujet âgé. La Revue de Médecine Interne 23:7, pages 632-637.
Crossref
Luigi Salvagno, Domenico Errante, Antonio Bianco, Valentina Palmisano, Ferruccio Ballerini, Massimo Boccalon, Savina Aversa & Silvio Monfardini. (2018) Treatment of Non-Hodgkin's Lymphoma in the Elderly. The Italian Studies. Tumori Journal 88:1_suppl1, pages S20-S25.
Crossref
Silvio Monfardini. (2018) Development of Geriatric Oncology in Italy. Tumori Journal 88:1_suppl1, pages S3-S4.
Crossref
Vittorina Zagonel, Silvio Monfardini, Umberto Tirelli, Antonino Carbone & Antonio Pinto. (2001) Management of hematologic malignancies in the elderly: 15-year experience at the Aviano Cancer Center, Italy. Critical Reviews in Oncology/Hematology 39:3, pages 289-305.
Crossref
Paul N. MainwaringDavid CunninghamWalter GregoryPeter HoskinBarry HancockAndrew J. NortonKen MacLennanPaul SmithGillian Vaughan HudsonDavid Linch. (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood 97:10, pages 2991-2997.
Crossref
Joseph O. Jacobson, Michael Grossbard, Lawrence N. Shulman & Donna Neuberg. (2000) CHOP Chemotherapy with Preemptive Granulocyte Colony-Stimulating Factor in Elderly Patients with Aggressive Non-Hodgkin's Lymphoma: A Dose-Intensity Analysis. Clinical Lymphoma 1:3, pages 211-217.
Crossref
Stuart M Lichtman. (2000) Aggressive lymphoma in the elderly. Critical Reviews in Oncology/Hematology 33:2, pages 119-128.
Crossref
Jonathan C. Yau, Colin Germond, Stefan Gluck, Christine Cripps, Shailendra Verma, Bruce F. Burns, Terry M. Koski, Diane C. Lister & Glenwood D. Goss. (1998) Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma. American Journal of Hematology 59:2, pages 156-160.
Crossref
Umberto Tirelli, Vittorina Zagonel, Domenico Errante, Lucia Fratino & Silvio Monfardini. (1998) Treatment of non-Hodgkin's lymphoma in the elderly: an update. Hematological Oncology 16:1, pages 1-13.
Crossref
Susan E. O’Reilly, Joseph M. Connors, Nicol Macpherson, Richard Klasa & Paul Hoskins. (1997) Malignant Lymphomas in the Elderly. Clinics in Geriatric Medicine 13:2, pages 251-263.
Crossref
Masahiko Oguchi, Itaru Izuno, Kazuyoshi Takei, Naoto Shikama, Shigeru Sasaki, Koutarou Gomi & Shusuke Sone. (1997) Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: Usefulness of local and regional irradiation and reduced dose chemotherapy. International Journal of Radiation Oncology*Biology*Physics 37:1, pages 87-92.
Crossref
Marcel Soesan. (2015) NON‐HODGKIN'S LYMPHOMA IN THE OLD OLD. Journal of the American Geriatrics Society 43:7, pages 837-837.
Crossref
V. Zagonel, R. Babare, M.C. Merola, R. Talamini, R. Lazzarini, U. Tirelli, A. Carbone & S. Monfardini. (1994) Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy. Annals of Oncology 5, pages S127-S132.
Crossref
E.M. Bessell, A. Coutts, J. Fletcher, P.J. Toghill, A.J. Moloney, I.O. Ellis, G. Hulman & D. Jenkins. (1994) Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology. European Journal of Cancer 30:9, pages 1337-1341.
Crossref
L. Salvagno, A. Contu, A. Bianco, L. Endrizzi, G.M. Schintu, N. Olmeo, S.M.L. Aversa, V. Chiarion-Sileni, M. Sorarú & M.V. Fiorentino. (1992) A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma. Annals of Oncology 3:10, pages 833-837.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.